Form 4: Elanco Executive Acquires Deferred Stock Units as Part of Compensation Plan

Sentiment:

Insider Transaction Disclosure


Elanco Animal Health Inc. Executive Vice President Rajeev A. Modi acquired 94.8137 deferred stock units, increasing his beneficial ownership to 6,650.4449 units.

Summary

  • Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation at Elanco Animal Health Inc. (ELAN), acquired deferred stock units.
  • The transaction date for the acquisition of derivative securities was July 25, 2025.
  • The acquisition involved 94.8137 deferred stock units.
  • The price per deferred stock unit was $14.92.
  • Following this transaction, Modi's beneficial ownership of deferred stock units increased to 6,650.4449 units.
  • Each deferred stock unit represents the right to receive one share of company common stock or its cash equivalent.
  • These units will settle in cash or shares upon termination of employment or during a specified future year, in accordance with the Executive Deferral and Stock Match Plan.

Sentiment

Score: 7

Explanation: This is a routine disclosure of executive compensation through deferred stock units, which generally indicates continued executive alignment with the company's long-term performance.

Positives

  • Executive Rajeev A. Modi increased his beneficial ownership in the company through the acquisition of deferred stock units, indicating continued alignment with shareholder interests.
  • The acquisition is part of the Executive Deferral and Stock Match Plan, a standard compensation mechanism for executives.

Negatives

  • None identified.

Risks

  • None explicitly mentioned in this Form 4 filing.

Future Outlook

Deferred stock units are scheduled to settle in cash or shares of company common stock following termination of employment or during a specified future year, in accordance with the Executive Deferral and Stock Match Plan.

Management Comments

  • None explicitly stated in the filing.

Industry Context

This Form 4 filing details a routine executive compensation event for Elanco Animal Health Inc., a company operating in the animal health sector. Such deferred compensation plans are common across various industries to align executive incentives with long-term company performance.

Comparison to Industry Standards

  • The acquisition of deferred stock units by an executive is a standard component of executive compensation packages, aligning the executive's long-term interests with the company's performance. This practice is consistent with compensation structures observed in other large pharmaceutical and animal health companies such as Zoetis Inc. or Merck Animal Health.

Related Party Transactions

  • Acquisition of deferred stock units by Rajeev A. Modi, an Executive Vice President, as part of the company's Executive Deferral and Stock Match Plan.

Stakeholder Impact

  • Shareholders: The acquisition of deferred stock units by an executive aligns management's long-term interests with shareholder value.

Next Steps

  • Settlement of deferred stock units will occur upon termination of employment or during a specified future year.

Key Dates

DateDescription
07/25/2025Date of earliest transaction and acquisition of deferred stock units.
07/29/2025Date the Form 4 was signed by the attorney-in-fact for Rajeev A. Modi.

Recommendation

hold

This Form 4 filing details a routine executive compensation event involving deferred stock units. It does not provide new financial performance data or strategic shifts that would warrant a change in investment recommendation. The transaction primarily serves to align executive incentives with long-term company performance, which is a neutral to slightly positive factor, thus supporting a 'hold' recommendation.

Keywords

Elanco, ELAN, Form 4, Insider Transaction, Deferred Stock Units, Executive Compensation, Rajeev A. Modi, Animal Health

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.